Your browser doesn't support javascript.
loading
Prevalence and Incidence of Neuromyelitis Optica Spectrum Disorder in Korea: Population Based Study.
Lee, Hye Lim; Kim, Jae Young; Seok, Jin Myoung; Hong, Yoon Ho; Lim, Nam Gu; Shin, Ha Young; Kim, Byung Jo; Hwang, Soon Young; Min, Ju Hong; Kim, Byoung Joon.
Afiliación
  • Lee HL; Department of Neurology, Korea University College of Medicine, Seoul, Korea.
  • Kim JY; Department of Digital Healthcare, Samsung Advanced Institute for Health Sciences & Technology, Seoul, Korea.
  • Seok JM; Department of Neurology, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea.
  • Hong YH; Department of Neurology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
  • Lim NG; Department of Medical Administration and Information, Daejeon Health Institute of Technology, Daejeon, Korea.
  • Shin HY; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Kim BJ; Department of Neurology, Korea University College of Medicine, Seoul, Korea.
  • Hwang SY; Department of Biostatistics, Korea University College of Medicine, Seoul, Korea.
  • Min JH; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim BJ; Neuroscience Center, Samsung Medical Center, Seoul, Korea.
J Korean Med Sci ; 35(17): e115, 2020 May 04.
Article en En | MEDLINE | ID: mdl-32356417
BACKGROUND: Although neuromyelitis optica spectrum disorder (NMOSD) is known to be a rare disease, its prevalence and incidence have not yet been studied in Korea. We performed a population-based study to examine the prevalence and incidence of NMOSD in Korea using data from the Korean National Health Insurance (NHI) claims database. METHODS: Data from 2013 to 2017 were obtained, with a washout period set as 2013 and 2014. The prevalence and incidence of NMOSD in 2016 and 2017 were calculated using population census data. Subjects were divided into 5 groups at 15-year intervals, depending on the age at which the diagnostic code was entered. The relative risk (RR) for each age group was compared with the oldest (≥ 60 years) age group. RESULTS: The overall prevalence was estimated to be 3.36 and 3.56 per 100,000 individuals, with an incidence of 0.41 and 0.65 per 100,000 individuals-year in 2016 and 2017, respectively. The mean age was 43.08 (standard deviation, 14.56) years, and the ratio of male to females was 1:4.7. The incidence was higher in female individuals aged between 30 and 59 years (RR, 2.8-3.05; P < 0.05). CONCLUSION: Nationwide prevalence of NMOSD in Korea was 3.36 and 3.56/100,000 and its incidence was 0.41 and 0.65/100,000-year in 2016 and 2017 respectively.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neuromielitis Óptica Tipo de estudio: Etiology_studies / Incidence_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: J Korean Med Sci Asunto de la revista: MEDICINA Año: 2020 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neuromielitis Óptica Tipo de estudio: Etiology_studies / Incidence_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: J Korean Med Sci Asunto de la revista: MEDICINA Año: 2020 Tipo del documento: Article